Dermatology
Multisystem effects of COVID-19: A concise review for practitioners
16 Sep, 2020 | 09:14h | UTCMultisystem effects of COVID-19: A concise review for practitioners – Postgraduate Medicine
Systematic review: Interventions for American cutaneous and mucocutaneous leishmaniasis
16 Sep, 2020 | 08:47h | UTCInterventions for American cutaneous and mucocutaneous leishmaniasis – Cochrane Library
Commentary on Twitter
Interventions for American cutaneous and mucocutaneous leishmaniasis https://t.co/3DFXrAUOEc Updated systematic review includes 75 studies with 6533 randomised participants. #ACML is a disfiguring disease caused by parasites, transmitted to humans by sandflies. @CochraneMoss
— The Cochrane Library (@CochraneLibrary) September 15, 2020
Cutaneous manifestations of COVID-19: An evidence-based review
15 Sep, 2020 | 08:55h | UTC
8 ways the coronavirus can affect your skin, from COVID toes, to rashes and hair loss
24 Aug, 2020 | 00:35h | UTC
Maculopapular eruptions associated with COVID ‐19
19 Aug, 2020 | 09:29h | UTC
[Abstract Only] Meta-analysis: Point-of-care ultrasonography for the diagnosis of skin and soft tissue abscesses
3 Aug, 2020 | 01:18h | UTCPoint-of-Care Ultrasonography for the Diagnosis of Skin and Soft Tissue Abscesses: A Systematic Review and Meta-analysis – Annals of Emergency Medicine (link to abstract – $ for full-text)
Commentary: POCUS for Abscess – A Large Meta-Analysis – Journal Feed
[Abstract Only] Trial of Roflumilast cream for chronic plaque psoriasis
16 Jul, 2020 | 08:15h | UTCTrial of Roflumilast Cream for Chronic Plaque Psoriasis – New England Journal of Medicine
Commentary: Researchers discover that topical treatment improves chronic plaque psoriasis – Mount Sinai Hospital
Review: Extrapulmonary Manifestations of COVID-19
13 Jul, 2020 | 00:28h | UTCExtrapulmonary manifestations of COVID-19 – Nature Medicine
Related review: Extra‐pulmonary complications of COVID‐19: a multi‐system disease? – Journal of Medical Virology
[Abstract Only] Randomized Trial: Ruxolitinib Cream for Treatment of Vitiligo
12 Jul, 2020 | 23:58h | UTCRuxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial – The Lancet
Related Commentary on Twitter
NEW—Treatment with ruxolitinib cream was associated with substantial repigmentation of vitiligo lesions up to 52 weeks of treatment, and all doses were well tolerated: finding from a randomised, controlled, phase 2 trial https://t.co/Td5nlsMcYI pic.twitter.com/CHvtspGstQ
— The Lancet (@TheLancet) July 10, 2020
Study Supports Link Between COVID-19 and ‘COVID Toes’
3 Jul, 2020 | 08:34h | UTCNews Release: Study supports link between COVID-19 and ‘COVID Toes’ – Wiley
Randomized Trial: Atezolizumab, Vemurafenib, and Cobimetinib for Advanced BRAFV600 Mutation-positive Melanoma
16 Jun, 2020 | 07:48h | UTC
Cohort Study: Fexofenadine use During Pregnancy Does Not Appear to Be Associated with Increased Risk of Adverse Fetal Outcomes
3 Jun, 2020 | 03:31h | UTCAssociation Between Fexofenadine Use During Pregnancy and Fetal Outcomes – JAMA Pediatrics (free for a limited period)
German Guidelines for the Diagnosis and Treatment of Perianal Dermatitis
1 Jun, 2020 | 03:49h | UTC
EULAR Recommendations for the Management of Psoriatic Arthritis
28 May, 2020 | 09:31h | UTCEditorial: EULAR PsA management recommendations 2019: can the recommendations be improved?
Commentary: EULAR releases recommendations for PsA management – Medicine Matters
Study: Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients
26 May, 2020 | 09:43h | UTC
Classification of the Cutaneous Manifestations of COVID‐19 with 375 Illustrative Cases
1 May, 2020 | 03:43h | UTCRelated: Journal articles on coronavirus with relevance for skin diseases and dermatology – Centre of Evidence Based Dermatology, University of Nottingham AND Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak – Journal of the American Academy of Dermatology
Great atlas with the different cutaneous manifestations of Covid-19.
Case Series: Characterization of Ischemic Cutaneous Lesions Associated with Covid-19
29 Apr, 2020 | 05:14h | UTCSee also: Journal articles on coronavirus with relevance for skin diseases and dermatology – Centre of Evidence Based Dermatology, University of Nottingham AND From ‘COVID Toes’ to Hives, These Are the Skin Conditions Dermatologists Think Could Be Signs of Coronavirus – TIME
ASCO Guideline: Systemic Therapy for Melanoma
3 Apr, 2020 | 03:57h | UTCSystemic Therapy for Melanoma: ASCO Guideline – Journal of Clinical Oncology
Randomized Trial: Treatment of Advanced AIDS-associated Kaposi Sarcoma in Resource-limited Settings
8 Mar, 2020 | 20:16h | UTC
FDA Safety Alert: Montelukast May Cause Serious Mental Health Side Effects
6 Mar, 2020 | 10:22h | UTCCommentary: Montelukast to Get Boxed Warning – NEJM Journal Watch (free)
NICE Guideline: Antimicrobial Prescribing Guidance for Impetigo
27 Feb, 2020 | 08:45h | UTCImpetigo: antimicrobial prescribing – National Institute for Health and Care Excellence (free)
Commentary: Antiseptic not antibiotic should be considered for impetigo – PharmaField (free)
Related: NICE Antimicrobial prescribing guidelines (resource covering many common conditions) AND NICE Summary of antimicrobial prescribing guidance – managing common infections (free PDF)
Meta-analysis: Prevalence, Incidence, and Risk of Cancer in Patients with Psoriasis and Psoriatic Arthritis
25 Feb, 2020 | 05:55h | UTCPrevalence, Incidence, and Risk of Cancer in Patients With Psoriasis and Psoriatic Arthritis: A Systematic Review and Meta-analysis – JAMA Dermatology (free for a limited period)
Randomized Trial: No Evidence That Daily Emollient During the First Year of Life Prevents Eczema
21 Feb, 2020 | 07:28h | UTCRelated Study: Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial – The Lancet (link to abstract – $ for full-text)
Commentaries: Emollients for prevention of atopic dermatitis in infancy – The Lancet (free) AND Daily moisturizer does not prevent eczema according to new research – News Medical (free)
Related Commentary on Twitter
NEW—No evidence that daily emollient during the first year of life prevents eczema in high-risk children and some evidence to suggest an increased risk of skin infections: finding from the BEEP randomised controlled trial https://t.co/nN4hr4TLdo pic.twitter.com/5QATGdRmWx
— The Lancet (@TheLancet) February 20, 2020
Management of Dermatologic Adverse Events from Cancer Therapies
18 Feb, 2020 | 08:05h | UTC
Study: Poor Performance of Apps Assessing Skin Cancer Risk
13 Feb, 2020 | 07:56h | UTCEditorial: The poor performance of apps assessing skin cancer risk (free)
Commentaries: Skin cancer diagnosis apps are unreliable and poorly regulated, study shows – eCancer News (free) AND Phone apps unreliable for detecting all cases of skin cancer – OnMedica (free)